thanks. so i guess the patent dispute is all that's left on the table, then we have gendicine phase IV trials in 2012.. unless something came out already about the patent
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.